Focal segmental glomerulosclerosis 4, susceptibility to

Synonyms: END-STAGE RENAL DISEASE, NONDIABETIC, SUSCEPTIBILITY TO

Summary

Focal segmental glomerulosclerosis (FSGS) is a pathologic entity associated clinically with proteinuria, the nephrotic syndrome (NPHS), and progressive loss of renal function. It is a common cause of end-stage renal disease (ESRD) (Meyrier, 2005). For a general phenotypic description and a discussion of genetic heterogeneity of focal segmental glomerulosclerosis and nephrotic syndrome, see FSGS1 (603278). [from OMIM]

Available tests

19 tests are in the database for this condition.

Check Related conditions for additional relevant tests.

Clinical tests (19 available)

Molecular Genetics Tests

Genes See tests for all associated and related genes

Associated genes Help
Genes reported to contribute to the condition.

APOL1
39 tests
Also known as: APO-L, APOL, APOL-I, FSGS4, APOL1
Summary: apolipoprotein L1

Imported from Human Phenotype Ontology (HPO)

Show all Hide all

Abnormality of the genitourinary system
- Focal segmental glomerulosclerosis
  Focal segmental glomerulosclerosis
  - MedGen UID: 4904
  - Concept ID: C0017668
  - Finding: Disease or Syndrome
  Abnormality of the genitourinary system
  See: Feature record | Search on this feature
- Stage 5 chronic kidney disease
  Stage 5 chronic kidney disease
  - MedGen UID: 384526
  - Concept ID: C2316810
  - Finding: Disease or Syndrome
  Abnormality of the genitourinary system
  See: Feature record | Search on this feature

Reviews

Clinical resources

Molecular resources

Consumer resources

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.